GB202308048D0 - Nucleic acid based vaccine - Google Patents

Nucleic acid based vaccine

Info

Publication number
GB202308048D0
GB202308048D0 GBGB2308048.4A GB202308048A GB202308048D0 GB 202308048 D0 GB202308048 D0 GB 202308048D0 GB 202308048 A GB202308048 A GB 202308048A GB 202308048 D0 GB202308048 D0 GB 202308048D0
Authority
GB
United Kingdom
Prior art keywords
nucleic acid
acid based
based vaccine
vaccine
nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2308048.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Curevac SE
Original Assignee
GlaxoSmithKline Biologicals SA
Curevac AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA, Curevac AG filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB2308048.4A priority Critical patent/GB202308048D0/en
Publication of GB202308048D0 publication Critical patent/GB202308048D0/en
Priority to DE202023106198.2U priority patent/DE202023106198U1/en
Priority to US18/494,893 priority patent/US20240156949A1/en
Priority to PCT/IB2023/060807 priority patent/WO2024089638A1/en
Pending legal-status Critical Current

Links

GBGB2308048.4A 2022-10-28 2023-05-30 Nucleic acid based vaccine Pending GB202308048D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB2308048.4A GB202308048D0 (en) 2023-05-30 2023-05-30 Nucleic acid based vaccine
DE202023106198.2U DE202023106198U1 (en) 2022-10-28 2023-10-26 Nucleic acid-based vaccine
US18/494,893 US20240156949A1 (en) 2022-10-28 2023-10-26 Nucleic Acid Based Vaccine
PCT/IB2023/060807 WO2024089638A1 (en) 2022-10-28 2023-10-26 Nucleic acid based vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2308048.4A GB202308048D0 (en) 2023-05-30 2023-05-30 Nucleic acid based vaccine

Publications (1)

Publication Number Publication Date
GB202308048D0 true GB202308048D0 (en) 2023-07-12

Family

ID=87060821

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2308048.4A Pending GB202308048D0 (en) 2022-10-28 2023-05-30 Nucleic acid based vaccine

Country Status (1)

Country Link
GB (1) GB202308048D0 (en)

Similar Documents

Publication Publication Date Title
IL287468A (en) Nucleic acid constructs and methods for their manufacture
GB2598497B (en) Nucleic acid hybridization methods
IL299169A (en) Self-amplifying sars-cov-2 rna vaccine
IL288633A (en) Stable target-editing guide rna having chemically modified nucleic acid introduced thereinto
EP4069731A4 (en) Nucleic acid linked immune-sandwich assay (nulisa)
GB202001501D0 (en) Nucleic acid nanostructures
GB202318721D0 (en) Nucleic acid based vaccine
GB202315944D0 (en) Nucleic acid based vaccine
GB202311985D0 (en) Nucleic acid based vaccine
GB202308048D0 (en) Nucleic acid based vaccine
GB202300950D0 (en) Nucleic acid based vaccine
GB202216023D0 (en) Nucleic acid based vaccine
GB202013940D0 (en) Regulatory nucleic acid sequences
GB201903391D0 (en) Nucleic acid amplification methods
GB202315659D0 (en) Nucleic acid preparation
GB202310075D0 (en) Nucleic acid preparation
EP3802821A4 (en) Direct nucleic acid sequencing method
GB202204098D0 (en) Nucleic Acid Construct
GB202014772D0 (en) Nucleic acid construct
GB202312280D0 (en) Functional nucleic acid
GB202019916D0 (en) RNA vaccine
IL310010A (en) Biologically produced nucleic acid for vaccine production
GB202117314D0 (en) Cyclic nucleic acid fragmentation
GB201913898D0 (en) Nucleic acid construct
EP3963056A4 (en) Vaccination using herpesvirus genomes in nucleic acid form